Safety and efficacy of adalimumab in combination with different doses of methotrexate in patients with psoriatic arthritis: Subanalysis of ADEPT

被引:0
|
作者
Gottlieb, Allice [1 ,2 ]
Teixeira, Henrique D. [3 ]
Varothai, Nupun [3 ]
Ganz, Fabiana [4 ]
Valdecantos, Wendell C. [3 ]
机构
[1] Tufts Univ, Sch Med, Boston, MA 02111 USA
[2] Tufts Med Ctr, Boston, MA USA
[3] AbbVie Inc, N Chicago, IL USA
[4] AbbVie Ag, N Chicago, IL USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
3478
引用
收藏
页码:AB268 / AB268
页数:1
相关论文
共 50 条
  • [1] IMPACT OF METHOTREXATE DOSE ON ADALIMUMAB EFFICACY IN PSORIATIC ARTHRITIS: A SUBANALYSIS OF ADEPT
    Aletaha, D.
    Li, Y.
    Hojnik, M.
    Ganz, F.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 785 - 785
  • [2] Efficacy of adalimumab by disease duration in psoriatic arthritis: Subanalysis of ADEPT
    Choy, Ernest
    Gladman, Dafna
    Sasso, Eric
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB186 - AB186
  • [3] Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept
    Choy, E. H. S.
    Gladman, D. D.
    Mease, P. J.
    Wordsworth, P.
    Ritchlin, C. T.
    Wang, H.
    Sasso, E. H.
    [J]. RHEUMATOLOGY, 2007, 46 : I18 - I18
  • [4] Adalimumab radiographic efficacy in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use, and clinical response: Subanalysis of ADEPT.
    Gladman, D. D.
    Mease, P. J.
    Choy, E. H. S.
    Ritchlin, C. T.
    Wang, H.
    Sasso, E. H.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S138 - S139
  • [5] Clinical efficacy and safety of adalimumab for psoriatic arthritis: 48-week results of ADEPT
    Mease, PJ
    Gladman, DD
    Ritchlin, CT
    Ruderman, EM
    Choy, EHS
    Steinfeld, SD
    Perdok, R
    Sasso, EH
    Weinberg, MA
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S215 - S215
  • [6] Adalimumab is efficacious in treating joint disease in early and established psoriatic arthritis: Subanalysis of ADEPT
    Choy, E.
    Gladman, D. D.
    Sasso, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 211 - 211
  • [7] Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept
    Kavanaugh, AF
    Ritchlin, CT
    Malaise, MG
    Wordsworth, P
    Birbara, CA
    Weinberg, MA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 325 - 325
  • [8] Efficacy, Pharmacokinetics, and Safety of Different Doses of Methotrexate in Combination With Adalimumab: Results From the Concerto Trial
    Burmester, Gerd R.
    Kivitz, Alan J.
    Kupper, Hartmut
    Arulmani, Udayasankar
    Florentinus, Stefan
    Goss, Sandra
    Rathmann, Suchitrita S.
    Fleischmann, Roy
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S183 - S184
  • [9] EFFICACY, PHARMACOKINETICS, AND SAFETY OF DIFFERENT DOSES OF METHOTREXATE IN COMBINATION WITH ADALIMUMAB: RESULTS FROM THE CONCERTO TRIAL
    Burmester, G.
    Kivitz, A.
    Kupper, H.
    Arulmani, U.
    Florentinus, S.
    Goss, S.
    Rathmann, S.
    Fleischmann, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 72 - 73
  • [10] EFFICACY, PHARMACOKINETICS AND SAFETY OF DIFFERENT DOSES OF METHOTREXATE IN COMBINATION WITH ADALIMUMAB: RESULTS FROM THE CONCERTO TRIAL
    Burmester, Gerd R.
    Kivitz, Alan
    Kupper, Hartmut
    Arulmani, Udayasankar
    Florentinus, Stefan
    Goss, Sandra
    Rathmann, Suchitrita
    Fleischmann, Roy
    [J]. RHEUMATOLOGY, 2014, 53 : 43 - 43